Definitely postmenopausal patients were more frequently diagnosed with node-negative disease (36% versus 26%), histological grade 3 tumours (38% versus 26%), and tumours expressing only one hormone receptor (26% versus 18%) when compared with patients with CIOFF. Here, NR4A1 is linked to neoplasm.